Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers. It also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.
Metrics to compare | VPT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVPTPeersSector | |
---|---|---|---|---|
P/E Ratio | −4.6x | −5.5x | −0.5x | |
PEG Ratio | −2.05 | −0.26 | 0.00 | |
Price/Book | −6.1x | 2.0x | 2.6x | |
Price / LTM Sales | 130.3x | 16.8x | 3.3x | |
Upside (Analyst Target) | - | 230.0% | 43.5% | |
Fair Value Upside | Unlock | −13.2% | 6.9% | Unlock |